Candida colonization of respiratory tract: to treat or not to treat, will we ever get an answer?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Time Trends in Prevalence and Antimicrobial Resistance of Respiratory Pathogens in a Tertiary Hospital in Rome, Italy: A Retrospective Analysis (2018-2023).Antibiotics (Basel, Switzerland) · 2025
   Article
2. Yeast species in the respiratory samples of COVID-19 patients; molecular tracking ofFrontiers in cellular and infection microbiology · 2024
   Article
3. Positive sputum culture ofChinese medical journal pulmonary and critical care medicine · 2023
   Article
4. Risk Factors for Candida Infection among Children Admitted to a Pediatric Intensive Care Unit in a Tertiary Care Centre in Southern India.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2022
   Article
5. Germs · 2021
   Article
6. Frontiers in cellular and infection microbiology · 2020
   Article
7. Effect ofAnnals of translational medicine · 2019
   Article
8. Implications of the presence of yeasts in tracheobronchial secretions of critically ill intubated patients.EXCLI journal · 2019
   Article
9. Outcomes associated with routine systemic antifungal therapy in critically ill patients with Candida colonization.Intensive care medicine · 2015
   Observational
10. Year in review in Intensive Care Medicine 2014: III. Severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics.Intensive care medicine · 2015
    Review

Corrections and comments

• Comment on
  Candida in the respiratory tract secretions of critically ill patients and the impact of antifungal treatment: a randomized placebo controlled pilot trial (CANTREAT study).2014

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as